TrialJournal of the American College of Cardiology2014

Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab.

Erik Stroes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.